Mednet Logo
CommunityMedical Oncology

How would you treat an MMR-proficient T2 N0 low-rectal cancer (measuring 2 cm extending 4-6 cm from the anal verge) in a patient who wishes to preserve his sphincter?

Is there data on neoadjuvant chemo-RT or chemo in this setting?
3 Answers
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · University of Pittsburgh School of Medicine
Answered on

Thanks for the question. I think a multidisciplinary approach is key here. First, I would make sure there is an MRI rectal performed confirming the stage of cancer and also clarify whether the patient would like to have organ preservation approach (not only the sphincter but also the rectum itself)....

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of Florida
Answered on

Chemo RT plus trans anal resection.

I’m pretty sure we have published UF data on the topic.

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Vanderbilt-Ingram Cancer Center
Answered on

OPERA trial is relevant here, focused on T2-3N0-1 rectal cancers: Gerard et al., PMID 36801007.

If you can find a regional Rad Onc to do rectal brachytherapy, that would maximize chances of organ preservation, but even with EBRT boost, organ preservation at 3-years is 68%, better than OPRA, understan...

Join for free or sign in to see the full answer